Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1960 May 1;111(5):643-65.
doi: 10.1084/jem.111.5.643.

Specific and non-specific immunity in experimental cryptococcosis in mice

Specific and non-specific immunity in experimental cryptococcosis in mice

D B LOURIA. J Exp Med. .

Abstract

The course of lethal cryptococcosis in mice was modified by immunization with the same strain or different strains of Cryptococcus neoformans. Protection was associated with a definite decrease in tissue fungus multiplication over the initial 7 days of infection. Such immunity was species-specific and did not protect against heterologous challenge with Staphylococcus aureus, Klebsiella pneumoniae, or Mycobacterium tuberculosis. Similar modification of lethal cryptococcosis was produced by intraperitoneal inoculation of 100 to 200 microg. of Salmonella endotoxin 7 days prior to challenge. In non-specifically (endotoxin) immunized mice there was only a minimal reduction in tissue cryptococcus census during the 1st week of infection. When small numbers of virulent cryptococci were injected intravenously into normal mice, tissue populations rose markedly in all organs studies during the first 7 days. A progressive fall in tissue fungus census was then observed in most mice during the next 6 months. The increase in resistance to cryptococcal challenge following specific immunization, the non-specific protection conferred by injection of bacterial endotoxin and the ability to control and eventually reduce infections with small inocula may well be dependent in each case on the development of specific antibody.

PubMed Disclaimer

References

    1. J Exp Med. 1953 Feb 1;97(2):189-206 - PubMed
    1. Annu Rev Physiol. 1954;16:467-90 - PubMed
    1. Am J Clin Pathol. 1954 Sep;24(9):1050-72 - PubMed
    1. Proc Soc Exp Biol Med. 1955 Nov;90(2):355-60 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1955 Nov;18(4):237-49 - PubMed